(19)

(11)

EP 4 401 727 A1

(12)

(43) Date of publication: 24.07.2024 Bulletin 2024/30 (21) Application number: 22869512.8 (22) Date of filing: 15.09.2022

(51) International Patent Classification (IPC):  A61K 31/407(2006.01) A61K 47/18(2017.01) A61K 47/10(2017.01) A61K 9/08(2006.01) (52) Cooperative Patent Classification (CPC): A61K 47/10; A61K 31/407; A61K 47/18; A61K 9/08; A61K 9/0019 (86) International application number: PCT/IB2022/058697 (87) International publication number: WO 2023/042107 (23.03.2023 Gazette 2023/12)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 17.09.2021 IN 202121042020 (71) Applicant: Intas Pharmaceuticals Ltd. Ahmedabad - 380054, Gujarat (IN)	(72) Inventors: SHAH, Nisarg Pravinkumar Ahmedabad 382210 (IN) SONI, Maheshkumar Parasmalji Ahmedabad 382210 (IN) DADHANIYA, Dhavalkumar Vallabhadas Ahmedabad 382210 (IN) SINGH, Ajeet Kumar Ahmedabad 382210 (IN) SEHGAL, Ashish Ahmedabad 382210 (IN) (74) Representative: Intas Pharmaceuticals  World Trade Center Moll de Barcelona, s/n Edifici Est, 6a planta 08039 Barcelona 08039 Barcelona (ES)